| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Humacyte, Inc. | Chief Medical Officer | Common Stock | 7.5K | $11.6K | $1.55 | Apr 10, 2025 | Direct |
| Humacyte, Inc. | Chief Medical Officer | Stock Options (right to buy) | 283K | Jan 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HUMA | Humacyte, Inc. | Apr 10, 2025 | 1 | $11.6K | 4 | Apr 14, 2025 | Chief Medical Officer |
| HUMA | Humacyte, Inc. | Jan 21, 2025 | 1 | $0 | 4 | Jan 23, 2025 | Chief Medical Officer |
| HUMA | Humacyte, Inc. | Dec 8, 2023 | 1 | $0 | 4 | Dec 12, 2023 | Chief Medical Officer |
| HUMA | Humacyte, Inc. | Dec 8, 2022 | 1 | $0 | 4 | Dec 12, 2022 | Chief Medical Officer |
| HUMA | Humacyte, Inc. | Apr 4, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Chief Medical Officer |
| HUMA | Humacyte, Inc. | Apr 4, 2022 | 0 | $0 | 3 | Apr 5, 2022 | Chief Medical Officer |